fecal microbiota spores, live-brpk
fecal microbiota spores, live-brpk is listed in the FDA National Drug Code directory with 1 NDC code, marketed under brand name including VOWST. Available dosage form: capsule.
Drug Details
- Generic Name
- fecal microbiota spores, live-brpk
- Brand Names
- VOWST
- Application Number
- BLA125757
- Sponsor
- Aimmune Therapeutics, Inc.
- NDC Codes
- 1
- Dosage Forms
- CAPSULE
- Routes
- ORAL
- Active Ingredients
- DONOR HUMAN STOOL SPORES (ETHANOL TREATED)
Indications and Usage
1 INDICATIONS AND USAGE VOWST is indicated to prevent the recurrence of Clostridioides difficile infection (CDI) in individuals 18 years of age and older following antibacterial treatment for recurrent CDI (rCDI). VOWST is indicated to prevent the recurrence of Clostridioides difficile infection (CDI) in individuals 18 years of age and older following antibacterial treatment for recurrent CDI (rCDI). ( 1 ) Limitation of Use: VOWST is not indicated for treatment of CDI. Limitation of Use: VOWST is not indicated for treatment of CDI.